Lygos
Lygos (W16) built and commercialized sustainable, high-performance…
Performance materials company that used proprietary biology and chemistry to develop sustainable, high-performance ingredients and polymers. The company raised more than $200 million, scaled manufacturing, and commercialized products across agriculture, cleaning, personal care, and other specialty-materials markets. Lygos ultimately concluded through two strategic sales (DOD-funded organization, BioMADE and other strategic acquirers).
- Website
- lygos.com
- City
- San Francisco
- Country
- United States
- YC batch
- Winter 2016
- Team
- 55 people
- Stage
- Growth stage
- AI-native
- No
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run lygos.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Lygos across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Lygos's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
